Blog

Opioid-related deaths in Ontario remain persistently high, driven largely by an unstable and unregulated drug supply. In response, harm reduction services, such as supervised consumption sites/consumption and treatment services and safer supply programs, have been implemented to reduce the risks of overdose and connect people who use drugs with essential healthcare and social services.

A 2019 study revealed more than 80 products available online with implied benefits to alcohol hangover. Since then, several developments may have influenced the market.

This article discusses how unintended side effects from the international regime of drug criminalization may serve to increase harmful drug use among some population segments and performs systematic scoping reviews of two putative underlying dynamics relating to violence victimization and the forbidden fruit or psychological reactance effect.

Current regulation frameworks for medicines struggle to address the combination of pharmacological and psychotherapeutic elements in psychedelic therapy.

Stigmatised attitudes, opinions on opioid use, and prior contact with People Who Use Drugs (PWUD) contribute to what policies are publicly supported and implemented to reduce drug-related deaths. This study examined how these variables relate to policy support for the implementation of supervised injection sites, laws protecting bystanders at the scene of an overdose, and over-the-counter naloxone.

We sought to examine nascent trends surrounding the impacts of police drug seizures in the period after a substantial public policy shift surrounding the personal possession of drugs in British Columbia (BC), Canada. We explored the intersection of drug testing and police opioid seizures in Vancouver, BC.

The global regulatory landscape for psilocybin and PSILO-AT remains highly variable, with significant differences in the scope and clarity of medical governance.

Although there is growing support for the protective effects of psychedelics on mental health, recent evidence finds racial and ethnic minorities gain fewer benefits.

The increasing incidence of opioid dependence linked to the consumption of unwashed poppy seeds (UPSs) is an emerging public health concern.

A recent meta-analysis in Drug Science, Policy and Law on the risk associated with the detection of tetrahydrocannabinol (THC) in blood and

This paper discusses the topic of safer injecting facilities with those who are likely to use them. Whilst more countries are adopting this

This article discusses the introduction of the safe drug consumption facility in Glasgow and considers some of its potential consequences.

In the UK, there are over 40,000 specialist clinicians who are eligible to prescribe cannabis-based medical products (CBMPs); however, only

This paper delves into the crucial yet complex relationship between federal laws and scientific research, centering on the Controlled Substa

MDMA (now called midomafetamine by the FDA) is a substituted amphetamine first synthesised in 1912 by Merck that has been developed over the

The prevalence of 3,4-methylenedioxymethamphetamine (MDMA) consumption is relatively high in Aotearoa New Zealand, but MDMA use has not been

MDMA has been developed over the past 30 years by the Multidisciplinary Association for Psychedelic Studies as a novel treatment for PTSD.

Authors Alex Stevens, Niamh Eastwood and Kirstie Douse Published March 24, 2024 Abstract In this review article, we develop the case for...

Authors Ksenia Cassidy, CJ Healy, Eva Henje and Wendy D’Andrea Published March 20, 2024 Abstract Challenging experiences in ayahuasca...

Authors Simon GD Ruffell, Sam Gandy, WaiFung Tsang, Rono Lopez, Nathan O’Rourke, Arsalan Akhtar, Nige Netzband, Jack Hollingdale, Daniel...

Authors Torsten Passie Published February 22, 2024 Abstract The emergence of a so-called psychedelic renaissance has been proposed to...